Cancer Leukemia-Myelogenous-Chronic

Title: Clinical Evaluation of the Xpert BCR-ABL Ultra Assay on the GeneXpert Instrument Systems
Description: The objective of this study is to establish the performance of an assay that detects mRNA transcript levels in patients diagnosed with CML. The study is conducted at locations within the United States. Testing is performed on peripheral blood specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions.
Drug/Procedure: Xpert BCR-ABL Ultra
NCT Number: 03421626
Notes:  
Start Date: 10/23/17
Status: Recruiting
Principal Name: Alan Langerak, MD
Contact Name: Olga Bittner, CCRC
Phone: (208)367-7954

 

Title: Specimen Collection for Analytical and/or Clinical Validation Studies of the Xpert BCR-ABL Ultra Assay on the GeneXpert Instrument Systems
Description: The objective of this study is to establish the performance of an assay that detects mRNA transcript levels in patients diagnosed with CML. The study is conducted at locations within the United States. Testing is performed on peripheral blood specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions.
Drug/Procedure: Xpert BCR-ABL Ultra
NCT/HDE #: N/A
Notes:  
Start Date: 7/21/17
Status: Recruiting
Principal Name: Alan Langerak, MD
Contact Name: Olga Bittner, CCRC
Phone: (208)367-7954